Ladero JM - Search Results

1

Predictive baseline criteria of primary therapeutic failure in chronic hepatitis C genotype 1.

Cuenca F, Fernández C, Devesa MJ, López-Alonso G, Mayol J, Suárez A, Ortega L, Díaz-Rubio M, Ladero JM. Cuenca F, et al. Among authors: ladero jm. Rev Esp Enferm Dig. 2010 Apr;102(4):234-8. doi: 10.4321/s1130-01082010000400003. Rev Esp Enferm Dig. 2010. PMID: 20486745 Free article.

2

[Therapeutic update in hepatitis C].

Devesa MJ, Cuenca F, Izquierdo S, Sánchez-Pobre P, Ladero JM, López-Alonso G, Díaz-Rubio M, Rey E. Devesa MJ, et al. Among authors: ladero jm. Rev Esp Quimioter. 2015 Sep;28 Suppl 1:48-51. Rev Esp Quimioter. 2015. PMID: 26365735 Free article. Review. Spanish.

3

"12 weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: two prognostic categories under the same label?

Ladero JM, López-Alonso G, Devesa MJ, Cuenca F, Agreda M, Ortega L, Suárez A, Díaz-Rubio M. Ladero JM, et al. Scand J Gastroenterol. 2008 Aug;43(8):979-83. doi: 10.1080/00365520801989969. Scand J Gastroenterol. 2008. PMID: 19086280

4

Non-invasive evaluation of the fibrosis stage in chronic hepatitis C: a comparative analysis of nine scoring methods.

Ladero JM, Delkader J, Ortega L, Fernández C, Devesa MJ, López-Alonso G, Mayol J, Cuenca F, Suárez A, Taxonera C, Díaz-Rubio M. Ladero JM, et al. Scand J Gastroenterol. 2010;45(1):51-9. doi: 10.3109/00365520903305544. Scand J Gastroenterol. 2010. PMID: 20030577

5

Predicting response to therapy in chronic hepatitis C: an approach combining interleukin-28B gene polymorphisms and clinical data.

Ladero JM, Martin EG, Fernández C, Carballo M, Devesa MJ, Martínez C, Suárez A, Díaz-Rubio M, Agúndez JA. Ladero JM, et al. J Gastroenterol Hepatol. 2012 Feb;27(2):279-85. doi: 10.1111/j.1440-1746.2011.06834.x. J Gastroenterol Hepatol. 2012. PMID: 21722179

6

Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.

Ladero JM, Torrejón MJ, Sánchez-Pobre P, Suárez A, Cuenca F, de la Orden V, Devesa MJ, Rodrigo M, Estrada V, López-Alonso G, Agúndez JA. Ladero JM, et al. Ann Hepatol. 2013 Mar-Apr;12(2):199-204. Ann Hepatol. 2013. PMID: 23396730 Free article.

7

HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.

Ladero JM, Ropero P, Ortega L, Taxonera C, González FA, López-Alonso G, Briceño O, Rodríguez-Agulló JL, González L, Villegas A, Díaz-Rubio M. Ladero JM, et al. Rev Esp Enferm Dig. 2003 Dec;95(12):829-36. Rev Esp Enferm Dig. 2003. PMID: 14972004 Free article. English, Spanish.

8

[Results of the treatment of chronic hepatitis C genotype 4--a comparative analysis with genotype 1].

López-Alonso G, Agreda M, Devesa MJ, Cuenca F, Suárez A, Ortega L, Díaz-Rubio M, Ladero JM. López-Alonso G, et al. Among authors: ladero jm. Rev Esp Enferm Dig. 2008 Apr;100(4):208-11. doi: 10.4321/s1130-01082008000400003. Rev Esp Enferm Dig. 2008. PMID: 18563977 Free article. Spanish.

9

Oscillations in serum ferritin associated with antiviral therapy in chronic hepatitis C.

Ladero JM, López-Alonso G, Devesa MJ, Cuenca F, Ortega L, Agreda M, Suárez A, Ropero P, Díaz-Rubio M. Ladero JM, et al. Rev Esp Enferm Dig. 2009 Jan;101(1):31-40. doi: 10.4321/s1130-01082009000100004. Rev Esp Enferm Dig. 2009. PMID: 19335031 Free article. English, Spanish.

10

GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic.

Martínez C, García-Martín E, Ladero JM, Herráez O, Ortega L, Taxonera C, Suárez A, Díaz-Rubio M, Agúndez JA. Martínez C, et al. Among authors: ladero jm. J Infect Dis. 2007 May 1;195(9):1320-3. doi: 10.1086/513569. Epub 2007 Mar 15. J Infect Dis. 2007. PMID: 17397002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page